Bridget E. Bunner

Array ( [id] => 6087865 [patent_doc_number] => 20110217294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'COMBINATION OF HGF INHIBITOR AND HEDGEHOG INHIBITOR TO TREAT CANCER' [patent_app_type] => utility [patent_app_number] => 12/935264 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217294.pdf [firstpage_image] =>[orig_patent_app_number] => 12935264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945113 [patent_doc_number] => 20110105733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'SINGLE VARIABLE DOMAINS AGAINST THE NOTCH PATHWAYS' [patent_app_type] => utility [patent_app_number] => 12/934766 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 90474 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105733.pdf [firstpage_image] =>[orig_patent_app_number] => 12934766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928896 [patent_doc_number] => 20110038855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'TRAIL AND METHODS OF MODULATING T CELL ACTIVITY AND ADAPTIVE IMMUNE RESPONSES USING TRAIL' [patent_app_type] => utility [patent_app_number] => 12/417487 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 36612 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038855.pdf [firstpage_image] =>[orig_patent_app_number] => 12417487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070044 [patent_doc_number] => 20110044894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/810006 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29218 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044894.pdf [firstpage_image] =>[orig_patent_app_number] => 12810006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6135223 [patent_doc_number] => 20110008891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'PARTIAL PEPTIDE OF LACRITIN' [patent_app_type] => utility [patent_app_number] => 12/922084 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7176 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008891.pdf [firstpage_image] =>[orig_patent_app_number] => 12922084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7522721 [patent_doc_number] => 08025876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Antibodies against a peptide epitope of apolipoprotein B' [patent_app_type] => utility [patent_app_number] => 12/394827 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11475 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/025/08025876.pdf [firstpage_image] =>[orig_patent_app_number] => 12394827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122088 [patent_doc_number] => 07704499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Antibodies against a peptide epitope of apoliporotein B' [patent_app_type] => utility [patent_app_number] => 12/394857 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11473 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704499.pdf [firstpage_image] =>[orig_patent_app_number] => 12394857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385230 [patent_doc_number] => 20090226475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/394744 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11484 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226475.pdf [firstpage_image] =>[orig_patent_app_number] => 12394744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315528 [patent_doc_number] => 20090280126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/394787 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11481 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280126.pdf [firstpage_image] =>[orig_patent_app_number] => 12394787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479566 [patent_doc_number] => 20090202523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'ANTIBODIES AGAINST A PEPTIDE EPITOPE OF APOLIPOROTEIN B' [patent_app_type] => utility [patent_app_number] => 12/394919 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11477 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202523.pdf [firstpage_image] =>[orig_patent_app_number] => 12394919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488764 [patent_doc_number] => 08029786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Antibodies against a peptide epitope of apolipoprotein B' [patent_app_type] => utility [patent_app_number] => 12/394886 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11471 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/029/08029786.pdf [firstpage_image] =>[orig_patent_app_number] => 12394886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434979 [patent_doc_number] => 20090169565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/393693 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162791 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169565.pdf [firstpage_image] =>[orig_patent_app_number] => 12393693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391135 [patent_doc_number] => 20090208448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Inhibition of angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/378209 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9411 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208448.pdf [firstpage_image] =>[orig_patent_app_number] => 12378209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9008950 [patent_doc_number] => 08524244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Targeted therapeutics based on engineered proteins that bind EGFR' [patent_app_type] => utility [patent_app_number] => 12/867406 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 31344 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575424 [patent_doc_number] => 20090142786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/364329 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 63187 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142786.pdf [firstpage_image] =>[orig_patent_app_number] => 12364329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530280 [patent_doc_number] => 07842502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Use of CXCL6 chemokine for inducing precursor cells into chondrocytes' [patent_app_type] => utility [patent_app_number] => 12/345369 [patent_app_country] => US [patent_app_date] => 2008-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8857 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842502.pdf [firstpage_image] =>[orig_patent_app_number] => 12345369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101773 [patent_doc_number] => 20110165265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'TRAIL VARIANTS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/808595 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 28336 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165265.pdf [firstpage_image] =>[orig_patent_app_number] => 12808595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10528211 [patent_doc_number] => 09254322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Compositions comprising E-selectin antagonists and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/747324 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 33378 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501680 [patent_doc_number] => 20090162368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'MECHANOSENSITIVE MAMMALIAN POTASSIUM CHANNEL ACTIVATABLE BY POLYUNSATURATED FATTY ACIDS' [patent_app_type] => utility [patent_app_number] => 12/329381 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 5588 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162368.pdf [firstpage_image] =>[orig_patent_app_number] => 12329381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062999 [patent_doc_number] => 20110200993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'NEW TREATMENT OF AUTOIMMUNE CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/743480 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8220 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200993.pdf [firstpage_image] =>[orig_patent_app_number] => 12743480 [rel_patent_id] =>[rel_patent_doc_number] =>)